|
| Tuesday, 17 January 2023, 14:25 HKT/SGT | |
| |
|
|
|
HONG KONG, Jan 17, 2023 - (ACN Newswire) - Beauty Farm Medical and Health Industry Inc. ("BeautyFarm Med" or "Company", stock code: 2373.HK), the largest provider of traditional beauty services in China in term of revenue in 2021, successfully listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today, with a board lots of 500 shares each. The stock price of BeautyFarm Med reached HK$30.5 at its debut today, representing an increase of 57.9% over the offer price. The share price closed at HK$29.65, up 53.5% and represents a market capitalization of HK$ 6.83billion.
Morgan Stanley Asia Limited, Haitong International Capital Limited and Huatai Financial Holdings (Hong Kong) Limited are the Joint Sponsors to the global offering; Morgan Stanley Asia Limited, Haitong International Securities Company Limited and Huatai Financial Holdings (Hong Kong) Limited are the Overall Coordinators, Joint Global Coordinators, Joint Bookrunners and Joint Managers to the global offering.
The Company states that the listing of BeautyFarm Med in Hong Kong marks a key milestone and unfolds a new chapter in the Company's development. Looking ahead, BeautyFarm Med will strategically expand its service network and marketing channels to enlarge its client base and increase brand awareness. The Company will also further enhance its operational efficiency and client experience by introducing new technologies, equipment and products, and expanding its service offerings. Moreover, the Company will continue to cultivate, recruit and retain high-caliber talent and strengthen its human resources management mechanism; and integrate industry resources and promote the development of industry standards by deepening cooperation with upstream suppliers and sharing its industry and management experience, thereby creating greater value for the clients, shareholders and employees.
Beauty Farm Medical and Health Industry Inc.
Beauty Farm Medical and Health Industry Inc. (stock code: 2373.HK) is a leading player in China's beauty and health management service industry, which has a large and loyal client base, extensive network with expansion efficiency, diversified services and product offerings as well as strong brand awareness. BeautyFarm Med is the largest provider of traditional beauty services and the fourth largest non-surgical aesthetic medical service provider in China with a market share of 0.2% and 0.6%, respectively, as measured by revenue in 2021 and according to Frost & Sullivan. The Company provides overall beauty and health management services through its well-established and widely recognized brand portfolio of BeautyFarm, Palaispa, CellCare and Neology. The service offerings of the Company cover traditional beauty services, aesthetic medical services as well as subhealth assessment and intervention services, across the full client lifecycle.
This press release is issued by Porda Havas International Finance Communications Group for and on behalf of Beauty Farm Medical and Health Industry Inc. For further information, please contact:
Porda Havas International Finance Communications Group
Tel: 852 3150 6788
Email: projectgarden.hk@pordahavas.com
Topic: Press release summary
Sectors: Healthcare & Pharm, Beauty & Skin Care
https://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
| |
Latest Press Releases
GMG Doubles Energy Density of 6 Minute Charging Graphene Aluminium-Ion Battery
Apr 15, 2026 19:59 HKT/SGT
|
|
|
Hitachi Energy and Samsung C&T expand strategic collaboration to accelerate grid infrastructure and reinforce energy security
Wednesday, April 15, 2026 5:17:00 PM
|
|
|
Mitsubishi Motors' Outlander PHEV Ranks No. 1 in Japan's PHEV Sales Category for the Second Consecutive Year
Wednesday, April 15, 2026 5:01:00 PM
|
|
|
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies
Apr 15, 2026 17:00 HKT/SGT
|
|
|
ASEAN Enterprises Move from AI Experiments to Engineering-Driven Deployment 
Apr 15, 2026 13:06 HKT/SGT
|
|
|
Exito Media Concepts Announces the 46th Edition of the Digital Transformation Summit Malaysia 2026
Apr 15, 2026 11:05 HKT/SGT
|
|
|
DENSO Establishes Strategic Partnership with Oracle to Modernize Core Supply Chain Systems
Wednesday, April 15, 2026 10:25:00 AM
|
|
|
Fujitsu and Chugoku Electric Power T&D sign IP licensing agreement to accelerate renewable energy integration and advance power transmission maintenance
Wednesday, April 15, 2026 10:07:00 AM
|
|
|
Doubleview Gold Corp. Announces Filing of Preliminary Economic Assessment Technical Report for the Hat Project
Apr 15, 2026 00:29 HKT/SGT
|
|
|
Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Apr 14, 2026 21:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
